Summaries & Associations of Study Results
TR-317 Chlorpheniramine Maleate
Target Organs and Levels of Evidence
NTP Technical Report Number 317
Produced from Chemtrack Database 09/19/01
| CHEMICAL/ CAS NUMBER | PEER REVIEW DATE | PRIMARY USES | ROUTE/EXPOSURE LEVELS | STUDY LABORATORY |
|---|---|---|---|---|
| CHLORPHENIRAMINE MALEATE 113-92-8 |
12/09/85 | ANTIHISTAMINE | Gavage MR: 0,15,30 MG/KG, FR: 0,30,60 MG/KG, MM: 0,25,50 MG/KG, FM: 0,100,200 MG/KG/50 PER GROUP | Battelle Columbus Laboratory |
| LEVELS OF EVIDENCE OF CARCINOGENICITY--ORGAN/TISSUE (NEOPLASM): | ||||
| MR: NO EVIDENCE | ||||
| FR: NO EVIDENCE | ||||
| MM: NO EVIDENCE | ||||
| FM: NO EVIDENCE | ||||
| NON-NEOPLASTIC LESIONS: | THYROID GLAND: CYSTS, FOLLICULAR CELL; HYPERPLASIA, FOLLICULAR CELL | |||
Web page last updated on February 10, 2006
